Empresa Infant Bacterial Therapeutics AB (publ) Other OTC
Acciones
Farmacéuticos
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 57 | 01/01/13 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 19/09/22 |
Chief Operating Officer | 57 | 20/10/14 | |
Jonas Rastad
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Agneta Heierson
PRN | Corporate Officer/Principal | - | - |
Leif Gallo
LAW | General Counsel | 65 | - |
Michael Owens
AUD | Comptroller/Controller/Auditor | 68 | 04/12/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 24/09/15 |
Chairman | 74 | 01/01/11 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 04/05/17 |
Director/Board Member | 63 | 15/05/18 | |
Eva Idén
BRD | Director/Board Member | 58 | 04/05/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 10 | 453 283 | 0 | 0 | 87,87 % |
Acción B | 1 | 13 018 137 | 11 837 506 ( 90,93 %) | 0 |
Información de la empresa
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21, Stockholm
+46 7 62 19 37 38
http://www.ibtherapeutics.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Pharmaceuticals: Major
|
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+18,88 % | 80,5 mil M | |
+14,11 % | 9147,41 M | |
-14,14 % | 4898,84 M | |
+43,39 % | 4494,57 M | |
+18,90 % | 4439,49 M | |
+7,93 % | 2189,17 M | |
-28,40 % | 2131,53 M | |
+15,93 % | 2100,61 M | |
-43,17 % | 1778,14 M |